Business
This new round of funding brings the company's total raise to roughly $95 million.
The company’s digital therapeutic aimed at treating depression in teens, SparkRx, was launched in October.
The Series A will support Proov’s new Complete testing product.
The fund seeks to capitalise on Europe’s rapidly expanding digital health landscape.
A new 3D-printed capsule planned for assisted suicide is being legalised in Switzerland.
This new infusion of cash comes roughly two years after the company closed a $60.75 million Series D round.
The prescription digital therapeutics company said the transaction generated approximately $175 million.
Its app aims to improve the quality of life and survival of cancer patients.
The project aims to help further digitise the country’ healthcare system.
The funding round comes months after the company raised $19.5 million in Series A financing.